Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Nov 13, 2023, before the open
10-Q filed Nov 13, 2023, 44 days after period end · 0001493152-23-040323
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | — | $0.00 | — | $7.00M |
| Net Income | -$11.84M | -$6.43M | -$7.04M | -$7.24M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.48 |
| -$1.00 |
| -$0.07 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.